
White & Case advises joint lead managers on Hikma Pharmaceuticals’ US$500 million bond issuance
1 min read
Global law firm White & Case LLP has advised Citigroup Global Markets Limited, Emirates NBD Bank PJSC, HSBC Bank plc, Mashreqbank psc and Mizuho International plc as joint lead managers on the issuance of US$500 million 5.125% notes due 2030 by Hikma Finance USA LLC, guaranteed by leading global pharmaceuticals company Hikma Pharmaceuticals PLC.
"White & Case advised the joint lead managers on a significant transaction that enables Hikma to further diversify its funding sources and once again successfully access the international debt capital markets," said White & Case partner Debashis Dey, who led the Firm's deal team.
The senior unsecured notes are listed on the International Securities Market of the London Stock Exchange.
The White & Case team that advised on the transaction was led by partner Debashis Dey (Dubai & London) and included local partner Marcin Zawadzki (Dubai) and associates Ola Sanni and Patrick Chindo (both Dubai).
Press contact
For more information please speak to your local media contact.